Bioenergetic Profiling in Glioblastoma Multiforme Patients with Different Clinical Outcomes

Area of Science:

• Biochemistry
• Oncology
• Metabolomics

Background:

• Cellular biomass accumulation increases bioenergetic and biosynthetic demands.
• Metabolic reprogramming is implicated in disease progression and response to extracellular signals.
• Glioblastoma multiforme (GBM) presents diagnostic and therapeutic challenges, necessitating novel biomarkers.

Purpose of the Study:

• To investigate the role of metabolic remodeling in glioblastoma multiforme's biological plasticity and disease severity.
• To establish a bioenergetic profile of glioblastoma multiforme using plasma metabolomics.

Main Methods:

• Coupled mixed-methods content analysis with mass spectrometry-based untargeted metabolomic analysis.
• Analyzed plasma samples from glioblastoma multiforme patients.
• Processed and analyzed metabolomic data to establish a bioenergetic profile.

Main Results:

• Established a bioenergetic profile characterized by mitochondrial function, redox state, lipids, and energy substrates.
• Identified epigenetic modulators, particularly microRNAs, as critical players in glioblastoma multiforme cell metabolism.
• Demonstrated that metabolic remodeling is linked to biological plasticity and disease severity in glioblastoma multiforme.

Conclusions:

• Metabolic remodeling, influenced by epigenetic factors like microRNAs, is central to glioblastoma multiforme's biological plasticity.
• Biological plasticity in glioblastoma multiforme serves as a mechanism for adaptation and treatment resistance.
• Bioenergetic profiling offers insights into the adaptive mechanisms driving glioblastoma multiforme progression and treatment resistance.